Integrated BioPharma, Inc. (OTCMKTS:INBP – Get Rating) was the target of a large increase in short interest in April. As of April 30th, there was short interest totalling 15,600 shares, an increase of 766.7% from the April 15th total of 1,800 shares. Based on an average daily trading volume, of 22,100 shares, the days-to-cover ratio is presently 0.7 days.
Shares of Integrated BioPharma stock opened at $0.72 on Thursday. The stock has a market capitalization of $21.48 million, a P/E ratio of 3.13 and a beta of 0.28. The stock has a 50 day moving average price of $0.80 and a two-hundred day moving average price of $0.93. Integrated BioPharma has a 12-month low of $0.27 and a 12-month high of $1.25.
Integrated BioPharma (OTCMKTS:INBP – Get Rating) last announced its earnings results on Thursday, February 10th. The company reported $0.03 earnings per share (EPS) for the quarter. The firm had revenue of $14.59 million during the quarter. Integrated BioPharma had a return on equity of 53.01% and a net margin of 11.87%.
Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments.
- Get a free copy of the StockNews.com research report on Integrated BioPharma (INBP)
- Corning Stock is a Technology Value Play
- Anheuser-Busch InBev May Need One More Quarter to Confirm a Buy Signal
- Wolverine Worldwide Is Ready To Rebound
- Wendy’s Growth Story Has Come To An End
- Can Six Flags(SIX) or Cedar Fair (FUN) Give Investors a Thrill Later This Year?
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.